13 results on '"Mourad, Waleed F."'
Search Results
2. Short-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary applicators.
- Author
-
Ma, John K., Mourad, Waleed F., Allbright, Robert, Packianathan, Satyaseelan, Harrell, Leslie M., Chinchar, Edmund, Nguyen, Alex, and Vijayakumar, Srinivasan
- Subjects
- *
RADIATION dosimetry , *CERVICAL cancer treatment , *COMPUTED tomography , *RADIOTHERAPY , *CANCER radiotherapy research - Abstract
Purpose: To compare the short-term toxicity and dosimetry of tandem and ring (TR), and tandem and ovoid (TO) applicators in treatment of gynecologic malignancy. Material and methods: Following pelvic external beam radiation therapy (EBRT), a total of 52 computed tomography- based plans from 13 patients with cervical cancer (FIGO IB2-IIIB) were evaluated for HDR brachytherapy. Prescription was 7 Gy to the ICRU point A for four weekly fractions. Gastrointestinal and genitourinary toxicities were evaluated. Clinical target volume (CTV) and organs at risk were delineated on CT scans. Bladder, rectum, and sigmoid mean doses and D2cc were calculated. Treatment time and irradiated tissue volume were compared. Percent of CTV receiving 100% (CTV100%) of the prescribed dose as well as the percent of the prescription dose covering 90% of the CTV (D90) were evaluated. Results: Gastrointestinal and genitourinary toxicities were not different between TO and TR applicators. No significant differences in the dose to the right and left point A, or the left point B were observed. TO delivered a higher dose to right point B. Organs at risk doses were similar between the two applicators, except mean rectal dose was lower for TO applicator. Overall, TO treats a larger tissue volume than TR. Mean treatment time was shorter for TR. Tumor coverage (D90 and CTV100%) was equivalent between TO and TR applicators. Conclusion: Although TO treats a larger tissue volume than TR, short-term toxicities and tumor coverage are similar. Long-term clinical outcomes will be elucidated with longer follow up period. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
3. Computerized tomography-based radiotherapy improves heterotopic ossification outcomes.
- Author
-
Mourad, Waleed F., Packianathan, Satya, Ma, John K., Yang, Claus (Chunli), Shourbaji, Rania A., He, Rui, Zhang, Zhen, Kanakamedala, Madhava Rao, Khan, Majid A., Mobit, Paul, Katsoulakis, Evangelia, Nabhani, Thomas, Jennelle, Richard, Russell, George V, and Vijayakumar, Srinivasan
- Subjects
- *
COMPUTED tomography , *RADIOTHERAPY , *OSSIFICATION , *HEALTH outcome assessment , *BONE fractures , *TREATMENT of fractures , *FOLLOW-up studies (Medicine) , *PATIENTS - Abstract
Abstract: Purpose: To report the impact of computerized tomography (CT) based radiotherapy (RT) on heterotopic ossification (HO) outcomes. Methods: This is a single institution, retrospective study of 532 patients who were treated for traumatic acetabular fractures (TAF). All patients underwent open-reduction internal-fixation (ORIF) of the TAF followed by RT for HO prophylaxis. Postoperative RT was delivered within 72h, in a single fraction of 7Gy. The patients were divided into 2 groups based on RT planning: CT (A) vs. clinical setup (B). Results: At a median follow up of 8years the incidence of HO was 21.6%. Multivariate regression analysis revealed that group (A) vs. (B) had HO incidence of 6.6% vs. 24.6% (p<0.001), respectively. Furthermore, HO Brooker grade ≥3 was observed in 2.2% vs. 10.8% (p=0.007) in group (A) vs. (B), respectively. Thus, the odds of developing HO and Brooker grades ≥3 were 4.7 and 4.5 times higher, respectively, in patients who underwent clinical setup. Conclusion: Our data suggest that using CT based RT allowed more accurate delineation of the tissues and better clinical outcomes. Although CT-based RT is associated with additional cost the efficacy of CT-based RT reduces the risk of HO, thereby decreasing the need for additional surgical interventions. [Copyright &y& Elsevier]
- Published
- 2013
- Full Text
- View/download PDF
4. Clinical validation and applications for CT-based atlas for contouring the lower cranial nerves for head and neck cancer radiation therapy.
- Author
-
Mourad, Waleed F., Young, Brett M., Young, Rebekah, Blakaj, Dukagjin M., Orhi, Nitin, Shourbaji, Rania A., Manolidis, Spiros, Gámez, Mauricio, Kumar, Mahesh, Khorsandi, Azita, Khan, Majid A., Shasha, Daniel, Blakaj, Adriana, Glanzman, Jonathan, Garg, Madhur K., Hu, Kenneth S., Kalnicki, Shalom, and Harrison, Louis B.
- Subjects
- *
CANCER tomography , *COMPUTED tomography , *CANCER radiotherapy , *CRANIAL nerves , *FACIAL paralysis , *HEAD & neck cancer treatment - Abstract
Summary: Objectives: Radiation induced cranial nerve palsy (RICNP) involving the lower cranial nerves (CNs) is a serious complication of head and neck radiotherapy (RT). Recommendations for delineating the lower CNs on RT planning studies do not exist. The aim of the current study is to develop a standardized methodology for contouring CNs IX–XII, which would help in establishing RT limiting doses for organs at risk (OAR). Methods: Using anatomic texts, radiologic data, and guidance from experts in head and neck anatomy, we developed step-by-step instructions for delineating CNs IX–XII on computed tomography (CT) imaging. These structures were then contoured on five consecutive patients who underwent definitive RT for locally-advanced head and neck cancer (LAHNC). RT doses delivered to the lower CNs were calculated. Results: We successfully developed a contouring atlas for CNs IX–XII. The median total dose to the planning target volume (PTV) was 70Gy (range: 66–70Gy). The median CN (IX–XI) and (XII) volumes were 10c.c (range: 8–12c.c) and 8c.c (range: 7–10c.c), respectively. The median V50, V60, V66, and V70 of the CN (IX–XI) and (XII) volumes were (85, 77, 71, 65) and (88, 80, 74, 64) respectively. The median maximal dose to the CN (IX–XI) and (XII) were 72Gy (range: 66–77) and 71Gy (range: 64–78), respectively. Conclusions: We have generated simple instructions for delineating the lower CNs on RT planning imaging. Further analyses to explore the relationship between lower CN dosing and the risk of RICNP are recommended in order to establish limiting doses for these OARs. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
5. The influence of pregnancy on heterotopic ossification post-displaced acetabular fractures surgical repair.
- Author
-
Mourad, Waleed F., Packianathan, Satya, Shourbaji, Rania A., Jennelle, Richard, Yang, Claus (Chunli), Mobit, Paul, Zhang, Zhen, Khan, Majid A., Graves, Mathew, Russell, George, and Vijayakumar, Srinivasan
- Subjects
- *
PREGNANCY complications , *TREATMENT of fractures , *BONE surgery , *ECTOPIC tissue , *OSSIFICATION , *BONE density , *CALCIUM metabolism - Abstract
Pregnancy is associated with maternal bone mineral density loss and modulation of calcium metabolism. We hypothesized that pregnancy may decrease the risk of heterotopic ossification (HO) after trauma. This is a single-institution, University of Mississippi Medical Center, retrospective study investigating the effect of pregnancy on the incidence HO after surgical repair (SR) of displaced acetabular fractures. Between January 1998 and 2010, 257 non-pregnant women (Group A) and 16 pregnant women (Group B) were identified. All the non-pregnant women received radiation therapy (RT) ± indomethacin. None of the pregnant women in group B received any prophylaxis. After a median follow-up of 6.6 years the incidence of HO in all patients was 27% (75/273). In Group A, non-pregnant, women who received RT ± indomethacin, 29% developed HO; HO risk was 0.4. In Group B, 16 pregnant patients, only one developed HO (6%); HO risk was 0.06. Thus, the risk of HO appears to be nearly six-fold higher in non-pregnant women despite prophylactic RT ± indomethacin. Our data suggest that pregnancy may be associated with a reduced risk of HO after SR of displaced acetabular fractures. Further analysis with a larger pregnant patient sample is necessary to confirm this finding. © 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 31: 944-948, 2013 [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. Lack of Adjuvant Radiotherapy May Increase Risk of Retropharyngeal Node Recurrence in Patients with Squamous Cell Carcinoma of the Head and Neck after Transoral Robotic Surgery.
- Author
-
Mourad, Waleed F., Blakaj, Dukagjin M., Kabarriti, Rafi, Young, Rebekah, Shourbaji, Rania A., Glanzman, Jonathan, Patel, Shyamal, Yaparpalvi, Ravindra, Kalnicki, Shalom, and Garg, Madhur K.
- Subjects
- *
HEAD & neck cancer treatment , *SQUAMOUS cell carcinoma , *CANCER relapse , *SURGICAL robots , *ADJUVANT treatment of cancer , *CANCER radiotherapy - Abstract
Purpose. Transoral robotic surgery (TORS) has increased in popularity in the management of squamous cell carcinoma of the head and neck. However, TORS does not address the neck or retropharyngeal nodes (RPN). In the current report, we highlight the impact of the lack of adjuvant radiotherapy on RPN recurrence after TORS. Materials and Methods. A 58-year-old Caucasian male presented with squamous cell carcinoma of the head and neck of unknown primary. He was offered radiotherapy as a definitive management for clinical stage T0N2aM0, stage IVA, but he opted to left neck dissection. Follow-up PET-CT scan revealed recurrence in the left base of tongue and right level II lymph node. He was offered radiotherapy which he declined and opted to TORS and right neck dissection. Follow-up PET-CT scan showed recurrence in left RPN for which he underwent salvage concurrent chemoradiotherapy to 70 Gy. Results. After a followup of 9 months from the date of salvage chemoradiotherapy completion, the patient is with no evidence of disease. Conclusions. TORS followed by adjuvant radiotherapy seems reasonable in the context of squamous cell carcinoma of the head and neck due to the odds of RPN involvement. Further reports are warranted to optimize post-TORS adjuvant treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
7. Prostate Cancer Dose Escalation via Simultaneous Integrated Brachytherapy Boost Delivered via Radioactive I125 vs. Pd103 Seeds Followed by External Beam Radiation Therapy.
- Author
-
Mourad, Waleed F., Rosenstein, Barry S., Shourbaji, Rania A., Ambrose, Robert, Dolan, James, Santoro, Joseph, Woode, Rudolph, Gamez, Mauricio, Lukens, John J., Harrison, Louis B., and Shasha, Daniel
- Published
- 2014
- Full Text
- View/download PDF
8. A Prolonged Time Interval Between Trauma and Prophylactic Radiation Therapy Significantly Increases the Risk of Heterotopic Ossification
- Author
-
Mourad, Waleed F., Packianathan, Satyaseelan, Shourbaji, Rania A., Zhang, Zhen, Graves, Mathew, Khan, Majid A., Baird, Michael C., Russell, George, and Vijayakumar, Srinivasan
- Subjects
- *
OSSIFICATION , *BONE surgery , *RADIOTHERAPY , *DISEASE incidence , *RETROSPECTIVE studies , *MEDICAL statistics - Abstract
Purpose: To ascertain whether the time from injury to prophylactic radiation therapy (RT) influences the rate of heterotopic ossification (HO) after operative treatment of displaced acetabular fractures. Methods and Materials: This is a single-institution, retrospective analysis of patients referred for RT for the prevention of HO. Between January 2000 and January 2009, 585 patients with displaced acetabular fractures were treated surgically followed by RT for HO prevention. We analyzed the effect of time from injury on prevention of HO by RT. In all patients, 700 cGy was prescribed in a single fraction and delivered within 72 hours postsurgery. The patients were stratified into five groups according to time interval (in days) from the date of their accident to the date of RT: Groups A ≤3, B ≤7, C ≤14, D ≤21, and E >21days. Results: Of the 585 patients with displaced acetabular fractures treated with RT, (18%) 106 patients developed HO within the irradiated field. The risk of HO after RT increased from 10% for RT delivered ≤3 days to 92% for treatment delivered >21 days after the initial injury. Wilcoxon test showed a significant correlation between the risk of HO and the length of time from injury to RT (p < 0.0001). Chi-square test and multiple logistic regression analysis showed no significant association between all other factors and the risk of HO (race, gender, cause and type of fracture, surgical approach, or the use of indomethacin). Conclusions: Our data suggest that there is higher incidence and risk of HO if prophylactic RT is significantly delayed after a displaced acetabular fracture. Thus, RT should be administered as early as clinically possible after the trauma. Patients undergoing RT >3 weeks from their displaced acetabular fracture should be informed of the higher risk (>90%) of developing HO despite prophylaxis. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
9. Evaluating the clinical acceptability of deep learning contours of prostate and organs‐at‐risk in an automated prostate treatment planning process.
- Author
-
Duan, Jingwei, Bernard, Mark, Downes, Laura, Willows, Brooke, Feng, Xue, Mourad, Waleed F., St Clair, William, and Chen, Quan
- Subjects
- *
PROSTATE , *DEEP learning , *PENILE prostheses , *RADIOTHERAPY treatment planning , *SEMINAL vesicles - Abstract
Background: Radiation treatment is considered an effective and the most common treatment option for prostate cancer. The treatment planning process requires accurate and precise segmentation of the prostate and organs at risk (OARs), which is laborious and time‐consuming when contoured manually. Artificial intelligence (AI)‐based auto‐segmentation has the potential to significantly accelerate the radiation therapy treatment planning process; however, the accuracy of auto‐segmentation needs to be validated before its full clinical adoption. Purpose: A commercial AI‐based contouring model was trained to provide segmentation of the prostate and surrounding OARs. The segmented structures were input to a commercial auto‐planning module for automated prostate treatment planning. This study comprehensively evaluates the performance of this contouring model in the automated prostate treatment planning process. Methods and materials: A 3D U‐Net‐based model (INTContour, Carina AI) was trained and validated on 84 computed tomography (CT) scans and tested on an additional 23 CT scans from patients treated in our local institution. Prostate and OARs contours generated by the AI model (AI contour) were geometrically evaluated against reference contours. The prostate contours were further evaluated against AI, reference, and two additional observer contours for comparison using inter‐observer variation (IOV) and 3D boundaries discrepancy analyses. A blinded evaluation was introduced to assess subjectively the clinical acceptability of the AI contours. Finally, treatment plans were created from an automated prostate planning workflow using the AI contours and were evaluated for their clinical acceptability following the Radiation Therapy Oncology Group‐0815 protocol. Results: The AI contours demonstrated good geometric accuracy on OARs and prostate contours, with average Dice similarity coefficients (DSC) for bladder, rectum, femoral heads, seminal vesicles, and penile bulb of 0.93, 0.85, 0.96, 0.72, and 0.53, respectively. The DSC, 95% directed Hausdorff distance (HD95), and mean surface distance for the prostate were 0.83 ± 0.05, 6.07 ± 1.87 mm, and 2.07 ± 0.73 mm, respectively. No significant differences were found when comparing with IOV. In the double‐blinded evaluation, 95.7% of the AI contours were scored as either "perfect" (34.8%) or "acceptable" (60.9%), while only one case (4.3%) was scored as "unacceptable with minor changes required." In total, 69.6% of the AI contours were considered equal to or better than the reference contours by an independent radiation oncologist. Automated treatment plans created from the AI contours produced similar and clinically acceptable dosimetric distributions as those from plans created from reference contours. Conclusions: The investigated AI‐based commercial model for prostate segmentation demonstrated good performance in clinical practice. Using this model, the implementation of an automated prostate treatment planning process is clinically feasible. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Lhermitte’s Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism.
- Author
-
Ko, Huaising C., Powers, Allison R., Sheu, Ren-dih, Kerns, Sarah L., Rosenstein, Barry S., Krieger, Stephen C., Mourad, Waleed F., Hu, Kenneth S., Gupta, Vishal, and Bakst, Richard L.
- Subjects
- *
HEAD & neck cancer treatment , *CANCER radiotherapy , *VOLUMETRIC analysis , *CANCER chemotherapy , *MEDICAL dosimetry - Abstract
Purpose/Objectives: We observed a number of patients who developed Lhermitte’s sign (LS) following radiation to the head and neck (H/N), since instituting volumetric modulated arc therapy (VMAT). We aimed to investigate the incidence of LS following VMAT-based RT without chemotherapy, and determine the dosimetric parameters that predict its development. We explored whether the role of inhomogeneous dose distribution across the spinal cord, causing a “bath-and-shower” effect, explains this finding. Methods and Materials: From 1/20/2010–12/9/2013, we identified 33 consecutive patients receiving adjuvant RT using VMAT to the H/N without chemotherapy at our institution. Patients’ treatment plans were analyzed for dosimetric parameters, including dose gradients along the anterior, posterior, right, and left quadrants at each cervical spine level. Institutional Review Board approval was obtained. Results: 5 out of 33 (15.2%) patients developed LS in our patient group, all of whom had RT to the ipsilateral neck only. LS patients had a steeper dose gradient between left and right quadrants across all cervical spine levels (repeated-measures ANOVA, p = 0.030). Within the unilateral treatment group, LS patients received a higher mean dose across all seven cervical spinal levels (repeated-measures ANOVA, p = 0.046). Dose gradients in the anterior-posterior direction and mean doses to the cord were not significant between LS and non-LS patients. Conclusions: Dose gradients along the axial plane of the spinal cord may contribute to LS development; however, a threshold dose within the high dose region of the cord may still be required. This is the first clinical study to suggest that inhomogeneous dose distributions in the cord may be relevant in humans. Further investigation is warranted to determine treatment-planning parameters associated with development of LS. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
11. Contemporary analysis of pelvic and para-aortic metastasis in endometrial cancer using the SEER registry.
- Author
-
Katsoulakis, Evangelia, Mattes, Malcolm D., Rineer, Justin M., Nabhani, Thomas, Mourad, Waleed F., Choi, Kwang, and Schreiber, David
- Subjects
- *
TREATMENT of endometrial cancer , *MEDICAL registries , *LYMPHATIC metastasis , *ENDOMETRIAL cancer , *RETROSPECTIVE studies , *PATIENTS ,PELVIS cancer ,DIAGNOSIS of endometrial cancer - Abstract
Objective To determine the incidence of regional lymph node involvement for early-stage endometrial cancer by using the Surveillance, Epidemiology, and End Results (SEER) registry. Methods In a retrospective study, data were analyzed from patients who were diagnosed with stage IA–IIB endometrioid adenocarcinoma and were treated between 1998 and 2003. The incidence of pelvic and para-aortic lymph node involvement was determined. Results Data were analyzed from 4052 patients. Incidences of pelvic and para-aortic lymph node metastases were: 1% and 0% in stage IA, grade 1 disease; 2% and 0% in IA, grade 2; 2% and 1% in IA, grade 3; 2% and 0% in IB, grade 1; 3% and 1% in IB, grade 2; 3% and 2% in IB, grade 3; 7% and 3% in IC, grade 1; 8% and 5% in IC, grade 2; 12% and 8% in IC, grade 3; 7% and 3% in IIA, grade 1; 10% and 4% in IIA, grade 2; 10% and 5% in IIA, grade 3; 8% and 4% in IIB, grade 1; 13% and 8% in IIB, grade 2; and 19% and 12% in IIB, grade 3. Conclusion Incidences of pelvic and para-aortic metastases were lower than previously reported. Patients at higher stages and grades had a 10% or higher risk of lymph node involvement and might benefit from aggressive therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
12. Oncologic and Toxicity Outcomes after Prostate Brachytherapy for HIV-Positive Patients.
- Author
-
Lukens, John Nicholas, Salant, Robert, Mourad, Waleed F., and Shasha, Daniel
- Published
- 2014
- Full Text
- View/download PDF
13. Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment.
- Author
-
Tubin, Slavisa, Khan, Mohammad K., Salerno, Gerardo, Mourad, Waleed F., Yan, Weisi, and Jeremic, Branislav
- Subjects
- *
NON-small-cell lung carcinoma , *STEREOTACTIC radiotherapy , *TREATMENT effectiveness , *LUNG cancer , *LYMPHOPENIA , *TUMORS - Abstract
Background: Radiotherapy-induced lymphopenia may be limiting the success of therapy and could also negatively affect the ability of immune system in mediating the bystander (BE) and abscopal effects (AE). A novel SBRT-based PArtial Tumor irradiation of HYpoxic clonogenic cells (SBRT-PATHY) for induction of the tumoricidal BE and AE by sparing the peritumoral immune microenvironment and regional circulating lymphocytes has been developed to enhance the radiotherapy therapeutic ratio of advanced lung cancer. The aim of this retrospective review of prospectively collected mono-institutional phase 2 study was to compare the outcomes between unconventional SBRT-PATHY and standard of care in unresectable stage IIIB/IV bulky NSCLC.Materials and Methods: Sixty patients considered inoperable or unsuitable for radical radio-chemotherapy were enrolled and treated using the following 3 regimens: SBRT-PATHY (group I, n = 20 patients), recommended standard of care chemotherapy (group II, n = 20 patients), and institutional conventional palliative radiotherapy (group III, n = 20 patients).Results: Median follow-up was 13 months. The 1-year overall survival was 75, 60, and 20% in groups 1, 2 and 3, respectively (p = 0.099). The 1-year cancer specific survival was 90, 60, and 20% in groups 1, 2, and 3, respectively (p = 0.049). Bulky tumor control rate was 95% for SBRT-PATHY compared with 20% in the other two groups. BE and AE were seen by SBRT-PATHY in 95 and 45% of patients, respectively. Multi-variate analysis for cancer specific survival was significant for treatment effect with SBRT-PATHY (p < 0.001) independent of age, sex, performance status, histology, stage, treated bulky site and tumor diameter. SBRT-PATHY resulted in lower toxicity (p = 0.026), and improved symptom control (p = 0.018) when compared to other two treatment options.Conclusion: SBRT-PATHY improved treatment outcomes in unresectable NSCLC and should be investigated in larger trials. Present study has been retrospectively registered on 8th of August 2019 by the ethic committee for Austrian region "Kärnten "in Klagenfurt (AUT), under study number A 31/19. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.